The impact of changing cigarette smoking habits and smoke-free legislation on orofacial cleft incidence in the United Kingdom: Evidence from two time-series studies.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 20 07 2021
accepted: 26 10 2021
entrez: 24 11 2021
pubmed: 25 11 2021
medline: 19 1 2022
Statut: epublish

Résumé

Both active and passive cigarette smoking have previously been associated with orofacial cleft aetiology. We aimed to analyse the impact of declining active smoking prevalence and the implementation of smoke-free legislation on the incidence of children born with a cleft lip and/or palate within the United Kingdom. We conducted regression analysis using national administrative data in the United Kingdom between 2000-2018. The main outcome measure was orofacial cleft incidence, reported annually for England, Wales and Northern Ireland and separately for Scotland. First, we conducted an ecological study with longitudinal time-series analysis using smoking prevalence data for females over 16 years of age. Second, we used a natural experiment design with interrupted time-series analysis to assess the impact of smoke-free legislation. Over the study period, the annual incidence of orofacial cleft per 10,000 live births ranged from 14.2-16.2 in England, Wales and Northern Ireland and 13.4-18.8 in Scotland. The proportion of active smokers amongst females in the United Kingdom declined by 37% during the study period. Adjusted regression analysis did not show a correlation between the proportion of active smokers and orofacial cleft incidence in either dataset, although we were unable to exclude a modest effect of the magnitude seen in individual-level observational studies. The data in England, Wales and Northern Ireland suggested an 8% reduction in orofacial cleft incidence (RR 0.92, 95%CI 0.85 to 0.99; P = 0.024) following the implementation of smoke-free legislation. In Scotland, there was weak evidence for an increase in orofacial cleft incidence following smoke-free legislation (RR 1.16, 95%CI 0.94 to 1.44; P = 0.173). These two ecological studies offer a novel insight into the influence of smoking in orofacial cleft aetiology, adding to the evidence base from individual-level studies. Our results suggest that smoke-free legislation may have reduced orofacial cleft incidence in England, Wales and Northern Ireland.

Sections du résumé

BACKGROUND
Both active and passive cigarette smoking have previously been associated with orofacial cleft aetiology. We aimed to analyse the impact of declining active smoking prevalence and the implementation of smoke-free legislation on the incidence of children born with a cleft lip and/or palate within the United Kingdom.
METHODS AND FINDINGS
We conducted regression analysis using national administrative data in the United Kingdom between 2000-2018. The main outcome measure was orofacial cleft incidence, reported annually for England, Wales and Northern Ireland and separately for Scotland. First, we conducted an ecological study with longitudinal time-series analysis using smoking prevalence data for females over 16 years of age. Second, we used a natural experiment design with interrupted time-series analysis to assess the impact of smoke-free legislation. Over the study period, the annual incidence of orofacial cleft per 10,000 live births ranged from 14.2-16.2 in England, Wales and Northern Ireland and 13.4-18.8 in Scotland. The proportion of active smokers amongst females in the United Kingdom declined by 37% during the study period. Adjusted regression analysis did not show a correlation between the proportion of active smokers and orofacial cleft incidence in either dataset, although we were unable to exclude a modest effect of the magnitude seen in individual-level observational studies. The data in England, Wales and Northern Ireland suggested an 8% reduction in orofacial cleft incidence (RR 0.92, 95%CI 0.85 to 0.99; P = 0.024) following the implementation of smoke-free legislation. In Scotland, there was weak evidence for an increase in orofacial cleft incidence following smoke-free legislation (RR 1.16, 95%CI 0.94 to 1.44; P = 0.173).
CONCLUSIONS
These two ecological studies offer a novel insight into the influence of smoking in orofacial cleft aetiology, adding to the evidence base from individual-level studies. Our results suggest that smoke-free legislation may have reduced orofacial cleft incidence in England, Wales and Northern Ireland.

Identifiants

pubmed: 34818369
doi: 10.1371/journal.pone.0259820
pii: PONE-D-21-23595
pmc: PMC8612573
doi:

Substances chimiques

Tobacco Smoke Pollution 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0259820

Subventions

Organisme : Medical Research Council
ID : MR/T002093/1
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Cleft Palate Craniofac J. 2020 May;57(5):552-559
pubmed: 31795734
Cleft Palate Craniofac J. 2005 May;42(3):255-9
pubmed: 15865458
BMJ. 2010 Jun 08;340:c2161
pubmed: 20530563
PLoS Med. 2012;9(3):e1001175
pubmed: 22412353
Eur J Med Genet. 2018 Sep;61(9):489-492
pubmed: 29753919
Birth Defects Res A Clin Mol Teratol. 2016 Sep;106(9):789-92
pubmed: 27256471
Thorax. 2011 Oct;66(10):862-5
pubmed: 21502102
Cleft Palate Craniofac J. 2003 Sep;40(5):481-5
pubmed: 12943441
Eur J Public Health. 2013 Oct;23(5):732-6
pubmed: 23804080
J Clin Epidemiol. 2011 Nov;64(11):1252-61
pubmed: 21640554
J Public Health (Oxf). 2015 Sep;37(3):547-54
pubmed: 25336275
Nat Rev Genet. 2011 Mar;12(3):167-78
pubmed: 21331089
Int J Epidemiol. 2013 Aug;42(4):1187-95
pubmed: 23760528
Epidemiology. 2005 May;16(3):311-6
pubmed: 15824545
J Epidemiol Community Health. 2012 Dec;66(12):1182-6
pubmed: 22577181
Annu Rev Public Health. 2017 Mar 20;38:39-56
pubmed: 28125392
Int J Oral Maxillofac Surg. 2013 Feb;42(2):177-84
pubmed: 23228693
PLoS Med. 2005 Aug;2(8):e124
pubmed: 16060722
BMC Med Res Methodol. 2019 Mar 6;19(1):46
pubmed: 30841848
Int J Epidemiol. 2017 Feb 1;46(1):348-355
pubmed: 27283160
Stat Med. 2006 Dec 30;25(24):4164-78
pubmed: 16991105
Sci Rep. 2016 Apr 22;6:23907
pubmed: 27103591
Ann Occup Hyg. 2010 Apr;54(3):272-80
pubmed: 20172917
BMJ. 2015 Jun 09;350:h2750
pubmed: 26058820
Sci Rep. 2015 Aug 13;5:13020
pubmed: 26268789
Int J Epidemiol. 2016 Dec 1;45(6):1866-1886
pubmed: 28108528
Epidemiology. 2019 May;30(3):311-316
pubmed: 30789434
Occup Environ Med. 2009 May;66(5):339-46
pubmed: 19208693
Am J Epidemiol. 2011 Nov 15;174(10):1101-7
pubmed: 21940800
J Clin Pharm Ther. 2002 Aug;27(4):299-309
pubmed: 12174032
Dev Dyn. 2006 May;235(5):1152-66
pubmed: 16292776
Biomed J. 2016 Apr;39(2):150-4
pubmed: 27372171
PLoS One. 2015 Mar 11;10(3):e0116963
pubmed: 25760440
J Craniomaxillofac Surg. 1996 Dec;24(6):378-82
pubmed: 9032607
Cleft Palate Craniofac J. 2011 Jan;48(1):66-81
pubmed: 20507242
Int J Epidemiol. 2001 Dec;30(6):1343-50
pubmed: 11821344
Environ Health Perspect. 2012 Mar;120(3):425-30
pubmed: 22169225
Lancet. 2014 May 3;383(9928):1549-60
pubmed: 24680633
Am J Epidemiol. 1974 May;99(5):325-32
pubmed: 4825599
BMJ. 2016 Sep 06;354:i4588
pubmed: 27601477
J Oral Maxillofac Res. 2015 Mar 30;6(1):e1
pubmed: 25937872
Development. 2012 Jan;139(2):231-43
pubmed: 22186724
Teratology. 1977 Dec;16(3):277-83
pubmed: 594911
Cleft Palate Craniofac J. 2021 Sep 27;:10556656211040015
pubmed: 34569861
Clin Epigenetics. 2017 Jun 8;9:63
pubmed: 28603561
Prev Med. 2019 Oct;127:105791
pubmed: 31398414
Arch Gen Psychiatry. 1992 Dec;49(12):983-8
pubmed: 1449385
Br J Orthod. 1998 Feb;25(1):21-30
pubmed: 9547971
Birth Defects Res A Clin Mol Teratol. 2007 Jan;79(1):8-15
pubmed: 17133404
Birth. 2019 Jun;46(2):222-233
pubmed: 30284325
Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Dec;122(6):680-690
pubmed: 27727103
Bull World Health Organ. 2004 Mar;82(3):213-8
pubmed: 15112010
Heart. 2010 Oct;96(19):1525-30
pubmed: 20736203
Biometrika. 1950 Dec;37(3-4):409-28
pubmed: 14801065
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33055094
BMC Health Serv Res. 2012 Jun 10;12:148
pubmed: 22682355
Cleft Palate Craniofac J. 2019 Feb;56(2):151-158
pubmed: 29727221
Cochrane Database Syst Rev. 2016 Feb 04;2:CD005992
pubmed: 26842828
J Craniofac Surg. 2018 Mar;29(2):396-399
pubmed: 29077685
Addiction. 2014 Dec;109(12):2035-43
pubmed: 25099127
Ethn Dis. 2010 Winter;20(1 Suppl 1):S1-146-9
pubmed: 20521404
N Engl J Med. 2010 Sep 16;363(12):1139-45
pubmed: 20843248
J Epidemiol Community Health. 2000 May;54(5):326-7
pubmed: 10814650
J Craniomaxillofac Surg. 2000 Aug;28(4):201-3
pubmed: 11110150
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131
Lancet. 2009 Nov 21;374(9703):1773-85
pubmed: 19747722

Auteurs

Matthew Fell (M)

Cleft Collective, Bristol Dental School, University of Bristol, Bristol, United Kingdom.

Craig Russell (C)

Scottish Cleft Service, Royal Hospital for Children, Glasgow, United Kingdom.

Jibby Medina (J)

Clinical Effectiveness Unit, Royal College of Surgeons of England, London, United Kingdom.

Toby Gillgrass (T)

Scottish Cleft Service, Royal Hospital for Children, Glasgow, United Kingdom.

Shaheel Chummun (S)

South West Cleft Service, University Hospitals Bristol and Weston NHS Trust, Bristol, United Kingdom.

Alistair R M Cobb (ARM)

South West Cleft Service, University Hospitals Bristol and Weston NHS Trust, Bristol, United Kingdom.

Jonathan Sandy (J)

Cleft Collective, Bristol Dental School, University of Bristol, Bristol, United Kingdom.

Yvonne Wren (Y)

Cleft Collective, Bristol Dental School, University of Bristol, Bristol, United Kingdom.

Andrew Wills (A)

Faculty of Health Sciences, University of Bristol, Bristol, United Kingdom.

Sarah J Lewis (SJ)

Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH